Hemagglutinin-specific CD4+ T cell (HA-specific CD4+ T cell)

CD4+ T cells recognizing Hemagglutinin (HA)-derived peptides presented on MHC class II molecules are a specialized subset of helper T lymphocytes central to the adaptive immune response against influenza viruses. These cells are activated when their T-cell receptors (TCRs) recognize specific HA peptide fragments, such as those from the HA1 or HA2 subunits, bound to Major Histocompatibility Complex (MHC) class II molecules on professional antigen-presenting cells (PMID: 25108024). Their primary biological function involves providing "help" to B cells for high-affinity antibody production and secreting cytokines like IFN-gamma and IL-2 to coordinate the broader immune response (PMID: 30249043). In therapeutic contexts, these cells are the functional targets of influenza vaccines, which aim to expand this population to ensure rapid recall responses upon viral exposure. While they are not a single molecular target, they are critical for vaccine efficacy and are monitored as biomarkers of immunogenicity using MHC-II tetramer technology (PMID: 21743014). Potential safety concerns include immunopathology or cross-reactivity with self-antigens, though these are rare in the context of standard vaccination.

Other names

HA-reactive CD4+ T cellInfluenza HA-specific T helper cellHemagglutinin-specific T lymphocyteHA-specific CD4+ T lymphocyte

Activation of T-cell receptors (TCR) by HA peptide-MHC class II complexes on antigen-presenting cells, leading to clonal expansion, cytokine secretion, and B-cell assistance.